NVDA
56
-4
GT
62
6
FTI
81
5
AVY
53
3
IPG
56
3
MAT
46
12
EFX
38
2
LYB
39
2
KLAC
47
4
DE
63
3
LH
43
-2
VZ
50
3
NEE
50
-5
EMN
60
4
BA
54
5
INTU
56
-4
VFC
53
5
PLD
56
8
MSFT
50
3
KMB
39
2
NVDA
56
-4
GT
62
6
FTI
81
5
AVY
53
3
IPG
56
3
MAT
46
12
EFX
38
2
LYB
39
2
KLAC
47
4
DE
63
3
LH
43
-2
VZ
50
3
NEE
50
-5
EMN
60
4
BA
54
5
INTU
56
-4
VFC
53
5
PLD
56
8
MSFT
50
3
KMB
39
2
Financhill
Back

Evoke Pharma Vs. Revance Therapeutics Industry Stock Comparison

Sell
11

EVOK
Evoke Pharma

Last Price:
4.35
Seasonality Move:
8.87%
Sell
9

RVNC
Revance Therapeutics

Last Price:
3.73
Seasonality Move:
6.97%
Sell
11
Evoke Pharma (EVOK) is a Sell

Is Evoke Pharma a Buy, Sell or Hold?

  • The current Evoke Pharma [EVOK] share price is $4.33. The Score for EVOK is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
  • EVOK is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
9
Revance Therapeutics (RVNC) is a Sell

Is Revance Therapeutics a Buy, Sell or Hold?

  • The current Revance Therapeutics [RVNC] share price is $3.73. The Score for RVNC is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
  • RVNC is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

EVOK Stock Price Chart

What is Evoke Pharma's stock price today?

  • The Evoke Pharma share price today is $4.33
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EVOK is experiencing selling pressure, which indicates risk of future bearish movement.

RVNC Stock Price Chart

What is Revance Therapeutics's stock price today?

  • The Revance Therapeutics share price today is $3.73
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RVNC is experiencing selling pressure, which indicates risk of future bearish movement.

EVOK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.26 Sell
Relative Strength Index (14 RSI): 38.44 Sell
Chaikin Money Flow: -36406 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.59 - 6.03) Sell
Bollinger Bands (100): (4.43 - 6.09) Sell

RVNC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.45 Sell
Relative Strength Index (14 RSI): 32.99 Sell
Chaikin Money Flow: -1111191 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.97 - 5.77) Sell
Bollinger Bands (100): (3.78 - 6.28) Sell

EVOK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.46 Sell
20-day SMA: 5.31 Sell
50-day SMA: 5.13 Sell
200-day SMA: 5.95 Sell
8-day EMA: 4.61 Sell
20-day EMA: 4.96 Sell
50-day EMA: 5.12 Sell
200-day EMA: 7.17 Sell

RVNC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.98 Sell
20-day SMA: 4.79 Sell
50-day SMA: 5.16 Sell
200-day SMA: 4.6 Sell
8-day EMA: 3.99 Sell
20-day EMA: 4.48 Sell
50-day EMA: 4.92 Sell
200-day EMA: 6.01 Sell

Evoke Pharma Earnings Growth & EVOK Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $22.78 per share, and an increase next year of $4.46 per share.

Revance Therapeutics Earnings Growth & RVNC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.51 per share, and an increase next year of $0.58 per share.

Evoke Pharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Revance Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):